GENE ONLINE|News &
Opinion
Blog

2021-04-17| SpecialTechnology

How Liquid Biopsies are Helping in Detection of Cancer Relapse?

by Ruchi Jhonsa
Share To
Circulating tumor cells (CTCs) are a rare subset of cells found in the blood of cancer patients, functioning as a seed for metastasis. Identifying them early on with liquid biopsies can help determine the occurrence of relapse. At the AACR virtual conference, Dr. Alberto Bardelli, Dr. Caroline Dive, and Dr. Sarah-Jane Dawson discussed how CTCs can be used to identify tumor evolution and minimal residual disease.

GO Prime with only $1.49 now

LATEST
Eli Lilly’s Tirzepatide Gets Approval in China for Weight Loss Management
2024-07-22
Roche Reports Positive Clinical Trial Results for Two Diabetes-Related Eye Disease Therapies
2024-07-19
7th Person in History Possibly Cured From HIV After Stem Cell Transplant for Acute Myeloid Leukemia
2024-07-19
Large RCT Finds Time-Lapse Imaging for Embryo Selection in IVF Does Not Improve Live Birth Rates
2024-07-19
Assessment of Supply Chain Risk Key to Improving Medicine Access
2024-07-18
SK Biopharma and Full-Life Sign US$571.5 Million Deal for Innovative Radiopharmaceutical FL-091
2024-07-18
Autoimmune Patients See Breakthrough Response to Allogeneic CD19-Targeted CAR-T Therapy
2024-07-18
EVENT
Scroll to Top